Kliniske studier for KOLS i New York
19 studier for KOLS søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Albany
- Research Site, Massapequa
- Research Site, New Windsor
- og 3 flere
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Trinity Medical, WNY- Site Number : 8400157, Buffalo
- Mid Hudson Medical Research - New Windsor- Site Number : 8400004, New Windsor
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 1. okt. 2026 · NCT07190222Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- New York Hospital Queens- Site Number : 8400058, Flushing
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07190209A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Mount Kisco
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 9. sep. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Mount Sinai, Icahn School of Medicine, New York
- Columbia University, New York
- Cornell University, New York
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Staten Island
- Research Site, Syracuse
- Research Site, The Bronx
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Buffalo
- Research Site, Cortland
- Research Site, Horseheads
- og 2 flere
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 3. sep. 2026 · NCT06883305A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Northwell Health Physician Partners at Chappaqua, Chappaqua
- New York Presbyterian Queens, Flushing
- Northern Westchester Hospital, Mount Kisco
RekruttererFase 2/3
Alder 35 til 80 · Alle kjønn · Oppdatert 31. aug. 2026 · NCT07363694A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
- Equity Medical LLC, New York
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 80 · Alle kjønn · Oppdatert 1. jul. 2026 · NCT06944925Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- Icahn School of Medicine at Mount Sinai, New York
Rekrutterer
Alder 22 og eldre · Alle kjønn · Oppdatert 23. jun. 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- Columbia University, New York
- Weill Cornell Medical Center, New York
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 30 til 55 · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05033990Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Mount Kisco
- GSK Investigational Site, New Windsor
RekruttererFase 3
Alder 40 til 80 · Alle kjønn · Oppdatert 9. apr. 2026 · NCT06961214Evaluation Of The Lung Microbiome In NTM Bronchiectasis
- New York University School of Medicine, New York
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 27. feb. 2026 · NCT02779478Lung Microbiome and Inflammation in Early COPD
- New York University School of Medicine, New York
RekruttererObservasjonsstudie
Alder 18 til 70 · Alle kjønn · Oppdatert 28. jan. 2026 · NCT02777879PiMZ Longitudinal Cohort (PiMZ Logic)
- Columbia University Irving Medical Center, New York
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 16. jan. 2026 · NCT06505603Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
- Weill Cornell Medical College and Weill Cornell Medical Center, Department of Genetic Medicine, New York
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 14. nov. 2025 · NCT01776398Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-management
- Ichan School of Medicine at Mount Sinai, New York
Rekrutterer
Alder 40 og eldre · Alle kjønn · Oppdatert 6. okt. 2025 · NCT06634810Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Our Lady of Lourdes Hospital, Binghamton
RekruttererObservasjonsstudie
Alder 50 og eldre · Alle kjønn · Oppdatert 5. aug. 2025 · NCT06122077PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
- Mount Sinai, New York
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 12. okt. 2023 · NCT05306743Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.